:max_bytes(150000):strip_icc()/VWH-MiraNorian-WeightLossDrugUpdate-4000x2700-c813fa5051604eec9c136047fb44d23a.png)
contrave with semaglutide and What's New in Obesity Treatment?-mvanhaasteren.nl Contrave vs. Wegovy for Weight
Description
| 40 comments on LinkedIn
Hengrui Pharma and Kailera Therapeutics Present #ADA2026 Data Showing #Ribupatide Could Emerge as a #Major #New GLP-1/GIP #Competitor in Both Oral and Injectable Obesity Markets The obesity treatment race continues to intensify
Not all GLP-1 products are FDA-approved
Looks like $LLY have, as expected, cemented their lead as the best in class drug makers and Im not sure how other pharmas are going to compete with this treatment
